Purple Biotech (PPBT) Competitors $3.11 -0.10 (-3.12%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PPBT vs. HCWB, CARA, GOVX, NERV, TLPH, MTEX, TENX, KZIA, AWH, and AIMShould you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include HCW Biologics (HCWB), Cara Therapeutics (CARA), GeoVax Labs (GOVX), Minerva Neurosciences (NERV), Talphera (TLPH), Mannatech (MTEX), Tenax Therapeutics (TENX), Kazia Therapeutics (KZIA), Aspira Women's Health (AWH), and AIM ImmunoTech (AIM). These companies are all part of the "pharmaceutical products" industry. Purple Biotech vs. HCW Biologics Cara Therapeutics GeoVax Labs Minerva Neurosciences Talphera Mannatech Tenax Therapeutics Kazia Therapeutics Aspira Women's Health AIM ImmunoTech HCW Biologics (NASDAQ:HCWB) and Purple Biotech (NASDAQ:PPBT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends, analyst recommendations and community ranking. Is HCWB or PPBT more profitable? Purple Biotech has a net margin of 0.00% compared to HCW Biologics' net margin of -978.03%. Purple Biotech's return on equity of -59.58% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets HCW Biologics-978.03% -385.90% -126.44% Purple Biotech N/A -59.58%-48.06% Which has higher valuation & earnings, HCWB or PPBT? Purple Biotech has lower revenue, but higher earnings than HCW Biologics. HCW Biologics is trading at a lower price-to-earnings ratio than Purple Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHCW Biologics$2.84M5.73-$24.99M-$1.04-0.41Purple BiotechN/AN/A-$19.88M-$13.00-0.24 Do analysts rate HCWB or PPBT? Purple Biotech has a consensus price target of $200.00, suggesting a potential upside of 6,330.87%. Given Purple Biotech's higher probable upside, analysts clearly believe Purple Biotech is more favorable than HCW Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/APurple Biotech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in HCWB or PPBT? 3.0% of HCW Biologics shares are owned by institutional investors. Comparatively, 9.6% of Purple Biotech shares are owned by institutional investors. 49.9% of HCW Biologics shares are owned by insiders. Comparatively, 3.0% of Purple Biotech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community favor HCWB or PPBT? Purple Biotech received 10 more outperform votes than HCW Biologics when rated by MarketBeat users. However, 100.00% of users gave HCW Biologics an outperform vote while only 94.12% of users gave Purple Biotech an outperform vote. CompanyUnderperformOutperformHCW BiologicsOutperform Votes6100.00% Underperform VotesNo VotesPurple BiotechOutperform Votes1694.12% Underperform Votes15.88% Does the media prefer HCWB or PPBT? In the previous week, HCW Biologics' average media sentiment score of 1.00 beat Purple Biotech's score of -0.77 indicating that HCW Biologics is being referred to more favorably in the media. Company Overall Sentiment HCW Biologics Positive Purple Biotech Negative Which has more risk and volatility, HCWB or PPBT? HCW Biologics has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, Purple Biotech has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. SummaryPurple Biotech beats HCW Biologics on 10 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Purple Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PPBT vs. The Competition Export to ExcelMetricPurple BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.14M$7.02B$5.33B$8.52BDividend YieldN/A7.92%5.07%4.13%P/E Ratio-0.2412.35128.4016.13Price / SalesN/A396.051,491.7792.21Price / CashN/A47.4339.5634.18Price / Book0.115.604.765.07Net Income-$19.88M$153.56M$118.92M$225.46M7 Day Performance-24.15%-1.46%-0.39%0.07%1 Month Performance-46.01%15.32%6.06%3.93%1 Year PerformanceN/A43.07%38.23%32.51% Purple Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PPBTPurple Biotech2.3588 of 5 stars$3.11-3.1%$200.00+6,330.9%N/A$4.14MN/A-0.2420HCWBHCW Biologics1.1279 of 5 stars$0.45+3.7%N/A-73.0%$16.91M$2.84M-0.4340Short Interest ↓Positive NewsGap UpCARACara Therapeutics4.1414 of 5 stars$0.31-1.1%$2.32+655.7%-75.5%$16.84M$20.97M-0.1555News CoverageGOVXGeoVax Labs3.748 of 5 stars$1.970.0%$12.67+543.2%-74.9%$16.52M$80,000.000.0017Positive NewsNERVMinerva Neurosciences4.0849 of 5 stars$2.35-1.7%$5.00+112.8%-47.6%$16.43MN/A-0.539Upcoming EarningsAnalyst ForecastTLPHTalphera2.4389 of 5 stars$0.93-0.9%$4.50+383.9%N/A$15.80M$650,000.00-1.4519Gap DownMTEXMannatech0.8825 of 5 stars$8.12-0.6%N/A-9.5%$15.27M$131.96M-12.89250Upcoming EarningsAnalyst ForecastNews CoverageTENXTenax Therapeutics3.205 of 5 stars$4.42+0.7%$170.67+3,761.2%-69.7%$15.07MN/A0.009News CoverageKZIAKazia Therapeutics2.2759 of 5 stars$5.62+4.1%$20.00+255.9%+35.7%$14.84M$20,000.000.0012Gap DownAWHAspira Women's Health1.2045 of 5 stars$0.92+2.0%$4.40+379.3%-80.8%$14.74M$9.15M-0.63110Analyst ForecastGap UpAIMAIM ImmunoTech1.3285 of 5 stars$0.25-3.4%$3.00+1,094.7%-43.7%$14.73M$200,000.00-0.4420 Related Companies and Tools Related Companies HCW Biologics Competitors Cara Therapeutics Competitors GeoVax Labs Competitors Minerva Neurosciences Competitors Talphera Competitors Mannatech Competitors Tenax Therapeutics Competitors Kazia Therapeutics Competitors Aspira Women's Health Competitors AIM ImmunoTech Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PPBT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
